Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Shares Outstanding (Entity) (2009 - 2026)

Updated

Alnylam Pharmaceuticals' Shares Outstanding (Entity) came in at 133.73 million for Q2 2026, up 2.1% from 130.98 million a year earlier and up 0.2% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends

For FY2025, Alnylam Pharmaceuticals' Shares Outstanding (Entity) was 132.38 million, up 2.4% from FY2024.

  • Shares Outstanding (Entity) has increased in each of the last 16 years, with a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 129.29 million in FY2024 (+2.8%), 125.79 million in FY2023 (+1.5%), 123.93 million in FY2022 (+3.1%) and 120.18 million in FY2021 (+3.2%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2009.
  • Year-over-year, Shares Outstanding (Entity) has increased for 65 consecutive quarters, with growth averaging 2.5% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 1.5% (Q4 2023) and 3.2% (Q2 2023) over the last five years.
  • Business Quant data shows ALNY's Shares Outstanding (Entity) at 133.44 million (Q1 2026), 132.38 million (Q4 2025) and 131.79 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.41 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 1.77 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 253.35 Mn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 133.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 133.73 Mn
Mar 31, 2026 133.44 Mn
Dec 31, 2025 132.38 Mn
Sep 30, 2025 131.79 Mn
Jun 30, 2025 130.98 Mn
Mar 31, 2025 130.31 Mn
Dec 31, 2024 129.29 Mn
Sep 30, 2024 128.84 Mn
Jun 30, 2024 128.02 Mn
Mar 31, 2024 126.46 Mn
Dec 31, 2023 125.79 Mn
Sep 30, 2023 125.45 Mn
Jun 30, 2023 124.90 Mn
Mar 31, 2023 124.24 Mn
Dec 31, 2022 123.93 Mn
Sep 30, 2022 122.99 Mn
Jun 30, 2022 120.99 Mn
Mar 31, 2022 120.73 Mn
Dec 31, 2021 120.18 Mn
Sep 30, 2021 119.48 Mn
API Access

Alnylam Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ALNY&period=max&api_key=YOUR_API_KEY